Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma. - McManus HD; Long JB; Westvold SJ; Leapman MS; Hurwitz ME; Mitchell AP; Pollack CE; Gross CP; Dinan MA (Clinical genitourinary cancer, 2025)